Beskrivelse
The objective of this conference is to present the latest progress in understanding of drug absorption mechanisms, to consider the importance of drug transporters, and to understand the design constraints for formulations within a biopharmaceutical context. Using new imaging, simulation and measurement tools that integrate knowledge from laboratory to clinic, the management of difficult subgroups in therapy and the best utilization of medicines will be considered, also guiding global regulatory harmonization. The molecular biological revolution, new drug design technologies, novel delivery approaches including nanomedicines, and the concurrent evolvement of regulatory principles for biosimilar products offer several exciting research topics for both academic and industrial scientists. The intent will be to utilise our knowledge at the cutting edge to consider challenges in current medication, including extremes of age and the impact of disease on effective and safe delivery of active pharmaceutical compounds.Periode | 24 jun. 2013 → 28 jun. 2013 |
---|---|
Begivenhedstype | Konference |
Placering | Uppsala, SverigeVis på kort |
Dokumenter og Links
Relateret indhold
-
Publikation
-
Vigabatrin absorption is mediated via the proton-coupled amino acid transporter PAT1 – in vitro and in vivo
Publikation: Konferencebidrag › Poster › Forskning